chlorambucil has been researched along with Benign Cerebellar Neoplasms in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsui, Y | 1 |
| Mineharu, Y | 1 |
| Noguchi, Y | 1 |
| Hattori, EY | 1 |
| Kubota, H | 1 |
| Hirata, M | 1 |
| Miyamoto, S | 1 |
| Sugiyama, H | 1 |
| Arakawa, Y | 1 |
| Kamikubo, Y | 1 |
1 other study available for chlorambucil and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
Topics: Cerebellar Neoplasms; Chlorambucil; Core Binding Factor Alpha 1 Subunit; Core Binding Factor Alpha 2 | 2022 |